You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Harvard Business School
Express Scripts
Moodys
Mallinckrodt

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Patent: 7,863,501

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,863,501
Title:B-type gene from oil palm
Abstract: The present invention relates generally to genetic sequences and their complementary forms capable of facilitating the modification of a phenotype of a plant. More particularly, the present invention relates to polynucleotide sequences defining B-type genes, to the proteins encoded thereby, to methods for isolating such polynucleotides and to nucleic acid constructs for the expression thereof. The present invention further provides cells, particularly transformed bacterial or plant cells and to differentiated tissue including whole plants and their progeny comprising cells which contain these nucleic acid constructs or parts of the constructs. Plants and parts of plants, such as flowering and reproductive parts including seeds, also form part of the present invention. The genetic sequences of the present invention may be used inter alia for the production of plants and, in particular, oil palm plants, which have modified phenotypes and/or which exhibits more highly desired characteristics such as, for example, male sterility or plants in which the sex ratio may be manipulated, and for the diagnosis and, preferably, elimination of the mantled phenotype.
Inventor(s): Van Der Linden; Cornelis Gerardus (Bennekom, NL), Alwee; Sharifah Shahrul Rabiah Syed (Selangor, MY), Smulders; Marinus Johannes Maria (Ka Ugchelen, NL), Choo; Cheah Suan (Selangor, MY), Abdullah; Meilina Ong Bt. (Selangor, MY), Eng; Ooi Siew (Selangor, MY)
Assignee: Malaysian Palm Oil Board (Selangor, MY)
Application Number:11/243,296
Patent Claims:see list of patent claims

Details for Patent 7,863,501

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Malaysian Palm Oil Board (Selangor, MY) 2024-09-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Malaysian Palm Oil Board (Selangor, MY) 2024-09-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Malaysian Palm Oil Board (Selangor, MY) 2024-09-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Moodys
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.